Androgen receptor signaling contributes to targeted therapy resistance in melanoma: Inhibiting androgen receptor improved treatment response in preclinical study - Science Daily

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers have shown. The findings provide a new target to combat therapeutic resistance and one possible answer to why men face a poore…

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a… [+5483 chars]

full article...